Treatment algorithm

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer

ACUTE

acute dystonic reactions

Back
1st line – 

diphenhydramine or benzatropine

Acute onset of dystonia is rare and, in most cases, is due to exposure to antidopaminergic agents. Initial evaluation in the emergent setting should include assessment of the airway.[45]​ If exposure to antidopaminergic agents is confirmed, give intravenous diphenhydramine or benzatropine and repeat if no effect is seen.

Some patients with poorly controlled generalised dystonia may develop acute worsening of their dystonia, which can be severe and life-threatening.

If you suspect overlapping neuroleptic malignant syndrome, malignant hyperthermia, serotonin syndrome, or other acute infectious, metabolic, or toxic derangement as a cause for the acute worsening, treatment should be directed at these underlying aetiologies. See Neuroleptic malignant syndrome (Management approach); Malignant hyperthermia (Management approach); Serotonin syndrome (Management approach).

Primary options

diphenhydramine: 50 mg intravenously as a single dose, may repeat in 20-30 minutes if necessary

OR

benzatropine mesilate: 2 mg intravenously as a single dose

ONGOING

generalised dystonia

Back
1st line – 

levodopa

It is important to establish whether patients with generalised dystonia are responsive to dopaminergic therapy. A therapeutic trial of levodopa with a decarboxylase inhibitor (carbidopa) should be given, which will determine whether the patient has dopa-responsive dystonia (DRD).[37]​ Responsiveness should be apparent within a few days to weeks.[38][46] DRD typically presents in childhood (DRD may comprise 5% to 10% of childhood-onset dystonia), but adults may also respond to treatment.[3]

Primary options

carbidopa/levodopa: children: consult specialist for guidance on dose; adults: 25/100 mg orally (immediate-release) three times daily initially, increase dose gradually according to response

Back
Plus – 

physiotherapy

Treatment recommended for ALL patients in selected patient group

Regular physiotherapy, bracing, and stretching are recommended to alleviate pain and prevent contractures.[37]

Stretching exercises are best provided by a physiotherapist.

Back
Consider – 

antispasmodic

Additional treatment recommended for SOME patients in selected patient group

Oral baclofen has demonstrated efficacy in improving gait in some patients with TOR1A (also known as DYT1) mutations, although no randomised controlled trials investigating its use exist.[49]

Clonazepam or zonisamide may also be helpful, particularly for myoclonic dystonia.[48][50]

Intrathecal baclofen has been proposed for use in cases of acquired dystonia when accompanied by spasticity. Intrathecal baclofen may also be considered in children when dystonia is accompanied by cerebral palsy.[51][52]

Primary options

baclofen: children: 2.5 mg/day orally initially, increase by 2.5 mg/dose increments every 3 days according to response, maximum 30 mg/day given in 3 divided doses; adults: 5 mg orally three times daily initially, increase by 5 mg/dose increments every 3 days according to response, maximum 80 mg/day

OR

clonazepam: children: consult specialist for guidance on dose; adults: 0.5 mg/day orally initially, increase by 0.5 mg/dose increments according to response, maximum 4 mg/day

OR

zonisamide: children and adults: consult specialist for guidance on dose

Secondary options

baclofen intrathecal: children and adults: consult specialist for guidance on dose

Back
Consider – 

treatment of underlying disease

Additional treatment recommended for SOME patients in selected patient group

Patients with acquired dystonia (e.g., Wilson's disease, Parkinson's disease) and a treatable underlying cause should receive appropriate disease-specific treatment.

Back
2nd line – 

trihexyphenidyl

If the dystonia does not improve with levodopa given for at least 4 weeks, the mainstay of oral symptomatic therapy consists of anticholinergic therapy.

Trihexyphenidyl was shown in a double-blind, randomised, placebo-controlled study to produce a 50% improvement in dystonia ratings.[47]

Anticholinergics in general are thought to be more effective in children than in adults, although this may be the result of higher doses being tolerated more easily by children.[48]

Primary options

trihexyphenidyl: children: consult specialist for guidance on dose; adults: 1-2 mg/day orally initially, increase according to response, maximum 15 mg/day given in 3-4 divided doses

Back
Plus – 

physiotherapy

Treatment recommended for ALL patients in selected patient group

Regular physiotherapy, bracing, and stretching are recommended to alleviate pain and prevent contractures.[37]

Stretching exercises are best provided by a physiotherapist.

Back
Consider – 

antispasmodic

Additional treatment recommended for SOME patients in selected patient group

Oral baclofen has demonstrated efficacy in improving gait in some patients with TOR1A (also known as DYT1) mutations, although no randomised controlled trials investigating its use exist.[49]

Clonazepam or zonisamide may also be helpful, particularly for myoclonic dystonia.[48][50]

Intrathecal baclofen has been proposed for use in cases of secondary dystonia when accompanied by spasticity, and may also be considered in children when dystonia is accompanied by cerebral palsy.[51][52]

Primary options

baclofen: children: 2.5 mg/day orally initially, increase by 2.5 mg/dose increments every 3 days according to response, maximum 30 mg/day given in 3 divided doses; adults: 5 mg orally three times daily initially, increase by 5 mg/dose increments every 3 days according to response, maximum 80 mg/day

OR

clonazepam: children: consult specialist for guidance on dose; adults: 0.5 mg/day orally initially, increase by 0.5 mg/dose increments according to response, maximum 4 mg/day

OR

zonisamide: children and adults: consult specialist for guidance on dose

Secondary options

baclofen intrathecal: children and adults: consult specialist for guidance on dose

Back
Consider – 

treatment of underlying disease

Additional treatment recommended for SOME patients in selected patient group

Patients with acquired dystonia (e.g., Wilson's disease, Parkinson's disease) and a treatable underlying cause should receive appropriate disease-specific treatment.

Back
3rd line – 

deep brain stimulation (DBS)

DBS of the internal globus pallidus is only used in patients who are refractory to medication. Referral to a neurosurgery centre experienced in DBS implantation in dystonia is strongly recommended, especially in the case of children, for whom early referral may be a factor in a successful outcome.[70]

DBS is approved by the US Food and Drug Administration under a humanitarian device exemption for treatment of primary generalised, segmental, cervical dystonia, or hemidystonia. DBS is thought to restore abnormal firing rates and patterns in the main outflow nucleus from the basal ganglia to the motor cortex.

One Cochrane review found that DBS may improve functional capacity and reduce symptom severity in adults with cervical, segmental, or generalised moderate to severe dystonia, and may improve quality of life in adults with generalised or segmental dystonia, although the evidence was of low quality.[63]

Although data are equivocal, there are several case series indicating that primary dystonias may be more likely than secondary dystonias to respond to a clinically meaningful degree, with the exception of tardive dystonias, which appear to respond very well to DBS of the internal globus pallidus.[67][68]

Back
Plus – 

physiotherapy

Treatment recommended for ALL patients in selected patient group

Regular physiotherapy, bracing, and stretching are recommended to alleviate pain and prevent contractures.[37]

Stretching exercises are best provided by a physiotherapist.

focal dystonia: other than adult isolated foot

Back
1st line – 

botulinum toxin

Most focal dystonias in adults and children do not respond to oral medications such as trihexyphenidyl and levodopa so botulinum toxin is usually the first line treatment.[39]​  A number of randomised, placebo-controlled trials for various movement disorders have demonstrated efficacy of botulinum toxin in reducing the severity of the dystonia as well as pain and disability, and in improving quality of life measures.[55][56]​​ The best evidence exists for cervical dystonia.[57][58][59][60]​​​​ [ Cochrane Clinical Answers logo ] ​​ One Cochrane review found a significant and clinically relevant reduction in cervical dystonia-specific impairment and pain following a single treatment session of botulinum toxin type A.[60]

Botulinum toxin dosing depends upon the size of the muscle being injected and the serotype used (type A or type B).[61]

Referral to a neurologist experienced in movement disorders and injection of botulinum toxin is strongly recommended when considering this treatment for cervical dystonia, blepharospasm, spasmodic dysphonia, writer's cramp, or focal lower limb dystonia.

Primary options

botulinum toxin type A: consult specialist for guidance on dose

OR

botulinum toxin type B: consult specialist for guidance on dose

Back
Plus – 

physiotherapy

Treatment recommended for ALL patients in selected patient group

Regular physiotherapy, bracing, and stretching are recommended to alleviate pain and prevent contractures.[37]

Stretching exercises are best provided by a physiotherapist.

Back
Consider – 

transcutaneous electrical nerve stimulation

Additional treatment recommended for SOME patients in selected patient group

Transcutaneous electrical nerve stimulation (TENS) has shown to be helpful for writer's cramp.[62]

Back
Consider – 

treatment of underlying disease

Additional treatment recommended for SOME patients in selected patient group

Patients with acquired dystonia (e.g., Wilson's disease, Parkinson's disease) and a treatable underlying cause should receive appropriate disease-specific treatment.

Back
Consider – 

speech therapy

Additional treatment recommended for SOME patients in selected patient group

Speech therapy may be helpful as an adjunct to botulinum toxin for laryngeal dystonia.[62]

Back
2nd line – 

deep brain stimulation (DBS)

DBS of the internal globus pallidus is only used in patients who are refractory to medication. Referral to a neurosurgery centre experienced in DBS implantation in dystonia is strongly recommended, especially in the case of children, for whom early referral may be a factor in a successful outcome.[70]

DBS is approved by the US Food and Drug Administration under a humanitarian device exemption for treatment of primary generalised, segmental, cervical dystonia, or hemidystonia. DBS is thought to restore abnormal firing rates and patterns in the main outflow nucleus from the basal ganglia to the motor cortex. One Cochrane review found that DBS may improve functional capacity and reduce symptom severity in adults with cervical, segmental, or generalised moderate to severe dystonia, and may improve quality of life in adults with generalised or segmental dystonia, although the evidence was of very low quality.[63]

Although data are equivocal, there are several case series indicating that primary dystonias may be more likely than secondary dystonias to respond to a clinically meaningful degree, with the exception of tardive dystonias, which appear to respond very well to DBS of the internal globus pallidus.[67][68]

Back
Plus – 

physiotherapy

Treatment recommended for ALL patients in selected patient group

Regular physiotherapy, bracing, and stretching are recommended to alleviate pain and prevent contractures.[37]

Stretching exercises are best provided by a physiotherapist.

adult isolated foot dystonia

Back
1st line – 

levodopa

Focal dystonias are often poorly responsive to oral medications. However, a trial of levodopa is suggested in adult isolated foot dystonia, especially if subtle signs of parkinsonism are present.

Primary options

carbidopa/levodopa: adults: 25/100 mg orally (immediate-release) three times daily initially, increase dose gradually according to response

Back
Plus – 

physiotherapy

Treatment recommended for ALL patients in selected patient group

Regular physiotherapy, bracing, and stretching are recommended to alleviate pain and prevent contractures.[37]

Stretching exercises are best provided by a physiotherapist.

Back
Consider – 

treatment of underlying disease

Additional treatment recommended for SOME patients in selected patient group

Patients with acquired dystonia (e.g., Wilson's disease, Parkinson's disease) and a treatable underlying cause should receive appropriate disease-specific treatment.

Back
2nd line – 

trihexyphenidyl

Focal dystonias are often poorly responsive to oral medications. However, trihexyphenidyl may be tried to a maximum tolerated dose.

Primary options

trihexyphenidyl: adults: 1-2 mg/day orally initially, increase according to response, maximum 15 mg/day given in 3-4 divided doses

Back
Plus – 

physiotherapy

Treatment recommended for ALL patients in selected patient group

Regular physiotherapy, bracing, and stretching are recommended to alleviate pain and prevent contractures.[37]

Stretching exercises are best provided by a physiotherapist.

Back
Consider – 

treatment of underlying disease

Additional treatment recommended for SOME patients in selected patient group

Patients with secondary dystonia (e.g., Wilson's disease, Parkinson's disease) and a treatable underlying cause should receive appropriate disease-specific treatment.

Back
3rd line – 

botulinum toxin

Many of the focal dystonias respond well to botulinum toxin with reduction of dystonia severity and pain and disability scores.

Botulinum toxin dosing depends upon the size of the muscle being injected and the serotype used (type A or type B).[61]

Referral to a neurologist experienced in movement disorders and injection of botulinum toxin is strongly recommended when considering this treatment for focal lower limb dystonia.

Primary options

botulinum toxin type A: consult specialist for guidance on dose

OR

botulinum toxin type B: consult specialist for guidance on dose

Back
Plus – 

physiotherapy

Treatment recommended for ALL patients in selected patient group

Regular physiotherapy, bracing, and stretching are recommended to alleviate pain and prevent contractures.[37]

Stretching exercises are best provided by a physiotherapist.

Back
Consider – 

treatment of underlying disease

Additional treatment recommended for SOME patients in selected patient group

Patients with acquired dystonia (e.g., Wilson's disease, Parkinson's disease) and a treatable underlying cause should receive appropriate disease-specific treatment.

Back
4th line – 

deep brain stimulation (DBS)

DBS is only used in patients who are refractory to medication. Subthalamic nucleus DBS has shown some benefit in patients with toe dystonia related to Parkinson’s disease.[64]​ Referral to a neurosurgery centre experienced in DBS implantation in dystonia is strongly recommended.

DBS is approved by the US Food and Drug Administration under a humanitarian device exemption for treatment of primary generalised, segmental, cervical dystonia, or hemidystonia. DBS is thought to restore abnormal firing rates and patterns in the main outflow nucleus from the basal ganglia to the motor cortex.

Back
Plus – 

physiotherapy

Treatment recommended for ALL patients in selected patient group

Regular physiotherapy, bracing, and stretching are recommended to alleviate pain and prevent contractures.[37]

Stretching exercises are best provided by a physiotherapist.

back arrow

Choose a patient group to see our recommendations

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer

Use of this content is subject to our disclaimer